MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.300
-0.010 (-0.76%)
May 13, 2026, 9:35 AM EDT - Market open
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $78.87 million as of May 13, 2026. Its market cap has increased by 33.29% in one year.
Market Cap
78.87M
Enterprise Value
45.07M
1-Year Change
33.29%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $78.87M, an increase of 54.35%. That is a compound annual growth rate of 12.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 79.48M | 35.75% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Champions Oncology | 83.60M |
| PolyPid | 83.58M |
| eXoZymes | 81.57M |
| Fortress Biotech | 79.39M |
| Annovis Bio | 79.08M |
| Actuate Therapeutics | 78.25M |
| Gain Therapeutics | 77.84M |
| TScan Therapeutics | 77.84M |